))
#42 - Nicole K. Paulk, CEO & Founder at Siren Biotechnology
Manage episode 430550374 series 3478706
Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Join us on the latest episode! Our Guest: Nicole K. Paulk, CEO & Founder at Siren Biotechnology.
What you'll get out of this episode:
- Nicole Paulk's early inspiration in gene therapy during her PhD at OHSU.
- The transition from academia to entrepreneurship amid COVID-19.
- Siren Biotechnology's innovative approach with AAV immunogene therapy.
- The challenges and successes in securing funding and navigating regulatory landscapes.
- The exciting transition of Siren Biotechnology from preclinical to clinical trials.
To Learn More About Our Guest And Their Company:
LinkedIn https://www.linkedin.com/in/nicolepaulk/
Company LinkedIn https://www.linkedin.com/company/siren-biotechnology-inc/
Website https://sirenbiotechnology.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
43 episodes
Share
